Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients

NCT07118176 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT07118176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07118176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 1, 2025
Completion date
September 7, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal carcinoma, bladder carcinoma, breast carcinoma, cervical carcinoma, cholangiocarcinoma, colorectal carcinoma, esophageal carcinoma, gastric carcinoma, head and neck carcinoma, hematopoietic and lymphatic system neoplasm, hepatocellular carcinoma, lung carcinoma, malignant adrenal gland neoplasm, malignant brain neoplasm, malignant neoplasm of unknown primary, malignant solid neoplasm, malignant testicular neoplasm, malignant uterine neoplasm, neuroendocrine neoplasm, ovarian carcinoma, pancreatic carcinoma, penile carcinoma, pleural carcinomatosis, primary peritoneal carcinoma, prostate carcinoma, salivary gland carcinoma, sarcoma, skin carcinoma, solitary fibrous tumor, thymus carcinoma, thyroid gland carcinoma, thyroid gland medullary carcinoma, urothelial carcinoma, vaginal carcinoma